Interacting Drugs |
Carteolol (ophthalmic) vs Dipyridamole |
Security Level |
 |
Mechanism |
Dipyridamole: May enhance the bradycardic effect of Beta-Blockers. |
Management |
Monitor therapy |
Carteolol (ophthalmic) vs Dipyridamole
Post Review about Carteolol (ophthalmic) vs Dipyridamole Click here to cancel reply.
Other Interactions of Carteolol (ophthalmic)
Other Interactions of Dipyridamole
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.